Clinical trials
2 active studies led by Hinge Bio, of 2 in all
Source: ClinicalTrials.gov, Studies with Hinge Bio (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Hinge Bio in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Hinge Bio or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by Hinge Bio, of 2 in all
Source: ClinicalTrials.gov, Studies with Hinge Bio (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Markets we cover where free public records show Hinge Bio: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Hinge Bio is in.
Stories on the topics Hinge Bio works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
Read
Skin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Read